ReVision Optics, Inc., a Lake Forest, CA-based ophthalmic surgical products company that specializes in the research, development and manufacturing of custom products to correct and maintain near vision, received $35m in capital funding.The financing was led by ProQuest Investments, with participation from returning investors Domain Associates, Canaan Partners and InterWest Partners.
This spring, the company began US clinical trials, which will evaluate the PresbyLens® corneal inlay for the correction of presbyopia by studying 400 patients over a two-year period.
ReVision Optics is actively pursuing regulatory approvals and market opportunities for the device worldwide.
ReVision Optics is actively pursuing regulatory approvals and market opportunities for the device worldwide.
It has CE mark and is approved for sale in Europe.
FinSMEs
25/05/2010